Key result
Multifunctional substernal lead demonstrates acute feasibility for integrated hemodynamic and electrical sensing in all 5 patients.
Why the study?
ICDs rely primarily on electrical signals, and hemodynamic sensing may provide complementary information about arrhythmia physiology that has not been integrated in a substernal lead.
Does a novel substernal lead integrating hemodynamic sensing, electrical sensing, and ventricular pacing demonstrate acute feasibility and performance in patients undergoing cardiac procedures?
Does a novel substernal lead integrating hemodynamic sensing, electrical sensing, and ventricular pacing demonstrate acute feasibility and performance in patients undergoing cardiac procedures?
A novel substernal lead integrating hemodynamic and electrical sensing with pacing capabilities is acutely feasible and can successfully capture the physiologic changes associated with ventricular arrhythmias.
Answers are grounded in this paper and cite their sources.
Acute feasibility shown in 5 patients; leaves open long-term safety, sensing reliability, and efficacy in larger prospective studies.
BACKGROUND Implantable cardioverter-defibrillators (ICDs) rely primarily on electrical signals to guide therapy. Hemodynamic sensing may provide complementary information about the immediate physiologic consequences of arrhythmias. OBJECTIVE Evaluate the acute feasibility and performance of a 3-dimensional substernal shock lead integrating hemodynamic sensing, electrical sensing, and ventricular pacing. METHODS This prospective first-in-human feasibility study enrolled 5 patients undergoing cardiac surgery or epicardial ventricular tachycardia (VT) ablation. A substernal shock lead was temporarily placed through a percutaneous subxiphoid approach using a dedicated delivery system. Lead placement and removal, adverse events, synchronized sensor signals, surface electrocardiograms, substernal electrograms, and pacing thresholds were assessed. RESULTS Lead placement and removal were successful in all patients without device- or procedure-related acute adverse events. Interpretable hemodynamic signals were obtained in all 5 patients and showed stable beat-to-beat temporal correspondence with the electrocardiogram and distinct rhythm-associated patterns across sinus rhythm (SR), atrial fibrillation, VT, and ventricular fibrillation (VF). All 147 VT episodes had interpretable hemodynamic-index recordings. The hemodynamic index decreased abruptly during VT and recovered after arrhythmia termination. Corresponding changes in the hemodynamic index were observed during transitions among VT, VF, and SR. Ventricular capture was achieved in all 5 patients at 11-17 V (mean, 13.8 V) at 0.5 ms. CONCLUSION Acute placement of this multifunctional substernal lead was feasible and enabled integrated hemodynamic and electrical sensing with acute ventricular capture. These findings provide preliminary human support for further development of physiology-guided extravascular ICD systems; chronic performance and clinical validation of the hemodynamic sensing algorithm require further study.
No takes yet. Share an insight, caveat, or question.
Cai et al. (2026) studied Patients undergoing cardiac surgery or epicardial ventricular tachycardia ablation (n=5). 3-dimensional substernal shock lead integrating hemodynamic sensing, electrical sensing, and ventricular pacing was evaluated on Lead placement and removal, adverse events, synchronized sensor signals, surface electrocardiograms, substernal electrograms, and pacing thresholds. Acute placement of a multifunctional substernal lead was feasible in all 5 patients, enabling integrated hemodynamic and electrical sensing with acute ventricular capture without adverse events.
Synapse has enriched 10 related papers. Consider them for comparative context: